News | November 13, 2023
Granules India Q2 FY24 PAT drops 30% at Rs. 102 Cr
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
Lack of technology transfer stands out as a formidable barrier
The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
The company has posted net profit of Rs.978.93 crores for the 6 months period ended September 30, 2023
India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Subscribe To Our Newsletter & Stay Updated
